Question · asked by 1 review
Magnesium sulphate vs hypertonic saline: Adverse events
- Population
- children up to 12 months old with acute bronchiolitis
- Intervention
- Magnesium sulphate
- Comparison
- hypertonic saline
- Outcome
- Adverse events
The review found no eligible studies for this question.
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Magnesium sulphate vs hypertonic saline Adverse events · children up to 12 months old with acute bronchiolitis The review found no eligible studies for this question. Magnesium sulphate for treating acute bronchiolitis in children up to two years of age (2020) · Cochrane Headline outcomes only | no estimate extracted | Not reported | No studies found |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Magnesium sulphate for treating acute bronchiolitis in children up to two years of age 2020 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
Related questions
The same intervention and outcome, asked in another population or against another comparator.
- Magnesium sulphate vs placebo · children up to 18 months old with acute bronchiolitis · 1 review
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.